Development of specific fluorogenic substrates for human β-N-Acetyl-D-hexosaminidase a for cell-based assays

Kazuki Miura, Yuka Aoyama, Yurika Natsu, Ryosuke Koyama, Takako Hirano, Toshiyuki Nishio, Wataru Hakamata

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Inhibitors of human β-N-acetyl-D-hexosaminidase (hHEX) A and human O-GlcNAcase (hOGA) reportedly play roles in multiple diseases, suggesting their potential for pharmacological chaperone (PC) therapy of Sandhoff disease (SD) and Tay-Sachs disease (TSD), as lysosomal storage diseases, and Alzheimer's disease and progressive supranuclear palsy, respectively. In particular, hHEXA inhibitors as PCs have been shown to successfully enhance hHEXA levels, leading to the chronic form of SD and TSD. In the diagnosis of enzyme deficiencies in SD and TSD, artificial hHEXA substrates based on 4-methylumbelliferone as a fluorophore are available and generally used; however, they do not have sufficient performance to screen for potential inhibitors for a PC therapy from compound libraries. Further, there are currently few fluorogenic substrates for hHEXA suitable for such requirements and there are no substrates ideal for cell-based inhibitor screening. Here, we clarified the difference in enzyme active site structure between hHEXA and hOGA from their tertiary structures. To develop lysosome-localized hHEXA-specific fluorogenic substrates based on the difference in their active site structures, our developed quinone methide cleavage substrate design platform was applied for the molecular design of substrates. Thereafter, we synthesized via the shortest route and evaluated novel three-color fluorogenic substrates for hHEXA that exhibited excellent specificity and sensitivity in three human cell lines. The designed substrates represent the first-in-a class of new substrates that can be utilized to screen hHEXA inhibitors in adherent human cultured cells.

Original languageEnglish
Pages (from-to)526-533
Number of pages8
JournalChemical and Pharmaceutical Bulletin
Volume68
Issue number6
DOIs
Publication statusPublished - 2020
Externally publishedYes

Keywords

  • Fluorogenic substrate
  • Inhibitor screening
  • Lysosomal storage disease
  • Pharmacological chaperone
  • β-N-acetyl-D-hexosaminidase

ASJC Scopus subject areas

  • Chemistry(all)
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Development of specific fluorogenic substrates for human β-N-Acetyl-D-hexosaminidase a for cell-based assays'. Together they form a unique fingerprint.

Cite this